These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 22324946)

  • 1. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
    Syngle A; Vohra K; Garg N; Kaur L; Chand P
    Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of spironolactone on endothelial dysfunction in rheumatoid arthritis.
    Syngle A; Vohra K; Kaur L; Sharma S
    Scand J Rheumatol; 2009; 38(1):15-22. PubMed ID: 18766955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of disease modifying anti-rheumatic drugs on subclinical atherosclerosis and endothelial dysfunction which has been detected in early rheumatoid arthritis: 1-year follow-up study.
    Guin A; Chatterjee Adhikari M; Chakraborty S; Sinhamahapatra P; Ghosh A
    Semin Arthritis Rheum; 2013 Aug; 43(1):48-54. PubMed ID: 23415602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of advanced glycation end-products inhibitor in osteoarthritis: a randomized, double-blind, placebo-controlled study.
    Garg S; Syngle A; Vohra K
    Clin J Pain; 2013 Aug; 29(8):717-24. PubMed ID: 23354008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
    Foster W; Carruthers D; Lip GY; Blann AD
    J Rheumatol; 2010 Apr; 37(4):711-6. PubMed ID: 20156948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis.
    van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
    Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
    Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
    Stirban A; Negrean M; Stratmann B; Gawlowski T; Horstmann T; Götting C; Kleesiek K; Mueller-Roesel M; Koschinsky T; Uribarri J; Vlassara H; Tschoepe D
    Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?
    de Groot L; Jager NA; Westra J; Smit AJ; Kallenberg CG; Posthumus MD; Bijl M
    Rheumatology (Oxford); 2015 Jul; 54(7):1257-61. PubMed ID: 25587178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis.
    de Man YA; Hazes JM; van de Geijn FE; Krommenhoek C; Dolhain RJ
    Arthritis Rheum; 2007 Jun; 57(5):716-22. PubMed ID: 17530669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of endothelial dysfunction in patients with rheumatoid arthritis.
    Sarli B; Baktir AO; Cebicci M; Dogan Y; Demirbas M; Kurtul S; Saglam H; Akpek M; Sahin O; Arinc H
    Angiology; 2014 Oct; 65(9):778-82. PubMed ID: 24078515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis.
    Tikiz C; Utuk O; Pirildar T; Bayturan O; Bayindir P; Taneli F; Tikiz H; Tuzun C
    J Rheumatol; 2005 Nov; 32(11):2095-101. PubMed ID: 16265685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy.
    Vitale C; Cerquetani E; Wajngarten M; Leonardo F; Silvestri A; Mercuro G; Fini M; Ramires JA; Rosano GM
    Ital Heart J; 2003 Sep; 4(9):627-32. PubMed ID: 14635381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular tumor necrosis factor alpha blockade reverses endothelial dysfunction in rheumatoid arthritis.
    Cardillo C; Schinzari F; Mores N; Mettimano M; Melina D; Zoli A; Ferraccioli G
    Clin Pharmacol Ther; 2006 Sep; 80(3):275-81. PubMed ID: 16952494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.
    Tanaka E; Mannalithara A; Inoue E; Hara M; Tomatsu T; Kamatani N; Singh G; Yamanaka H
    Ann Rheum Dis; 2008 Aug; 67(8):1153-8. PubMed ID: 17971459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
    Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
    Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis.
    Wiacek R; Kolossa K; Jankowski T; Jeka S; Karmowski A; Karmowski M; Gworys B
    Adv Clin Exp Med; 2012; 21(3):337-42. PubMed ID: 23214197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.
    Wållberg-Jonsson S; Caidahl K; Klintland N; Nyberg G; Rantapää-Dahlqvist S
    Scand J Rheumatol; 2008; 37(1):1-5. PubMed ID: 18189187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.